| Funding Opportunity ID: |
320105 |
| Opportunity Number: |
CDC-RFA-GH20-2085 |
| Opportunity Title: |
Quality Facility and Community-Based HIV Prevention, Case Finding, Care and Treatment, and Viral Suppression to Reach Epidemic Control in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.067 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-CDC-CGH |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control – CGH |
| Posted Date: |
Dec 27, 2019 |
| Close Date: |
Feb 27, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Last Updated Date: |
Dec 27, 2019 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$0 |
| Expected Number of Awards: |
2 |
| Description: |
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $60,000,000 for Year 1, subject to the availability of funds. This NOFO builds on previous activities for HIV case finding and clinical services in Cameroon. Activities funded under this NOFO will support technical assistance (TA) and service implementation around key strategies for improving HIV case-identification, linkage and same day antiretroviral therapy (ART) initiation, ART adherence and retention in care, and prevention of mother-to-child transmission (PMTCT) and early infant diagnosis (EID) uptake. Activities supporting health systems strengthening for HIV services in Cameroon will also be supported. Recipient(s) will be expected to implement high quality, well-targeted, innovative strategies to achieve epidemic control in five regions of Cameroon. The recipient(s) will be expected to provide TA, capacity building, and service implementation across the HIV clinical cascade. The recipient(s) will also be expected to provide differentiated models for HIV case identification, care, and treatment to key and priority population (KP/PP) groups, including (but not limited to) infants, children, adolescents, men, pregnant and breastfeeding women. |
| Version: |
1 |
|
